Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Epilepsy, Complex Partial

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Epilepsy, Complex Partial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Markand, ON; Park, HM; Shen, W; Siddiqui, AR; Wellman, HH; Worth, RM1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Epilepsy, Complex Partial

ArticleYear
Single photon imaging computed tomography (SPECT) for localization of epileptogenic focus in patients with intractable complex partial seizures.
    Epilepsy research. Supplement, 1992, Volume: 5

    Topics: Adolescent; Adult; Child; Dominance, Cerebral; Electroencephalography; Epilepsy, Complex Partial; Female; Humans; Iodobenzenes; Male; Middle Aged; Psychosurgery; Temporal Lobe; Tomography, Emission-Computed, Single-Photon

1992